HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=days_late&start=50100",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=days_late&start=49500",
"results": [
{
"registry_id": "NCT07283497",
"publication_url": "https://clinicaltrials.gov/study/NCT07283497",
"title": "Itraconazole Therapy In Bronchiectasis With Airway Mold: A Single-Arm Pilot Trial Of Feasibility, Safety, And Impact On Respiratory Symptoms And Airway Microbiome Diversity",
"has_exemption": false,
"start_date": "2026-08-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07551583",
"publication_url": "https://clinicaltrials.gov/study/NCT07551583",
"title": "A Phase II Single Arm Study to Evaluate Safety and Preliminary Efficacy of Nivolumab Plus AVD in Pediatric, Adolescent, And Young Adult Patients With Newly Diagnosed Early-stage Non-bulky Classical Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-08-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07654426",
"publication_url": "https://clinicaltrials.gov/study/NCT07654426",
"title": "A Randomized Study of Dexrazoxane or Liposomal Doxorubicin in Newly Diagnosed Diffuse Large B-cell Lymphoma at High Risk for Heart Failure Events: the CARDIOPROTECT Trial",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07398404",
"publication_url": "https://clinicaltrials.gov/study/NCT07398404",
"title": "A Multiple Health Behavior Change Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07701928",
"publication_url": "https://clinicaltrials.gov/study/NCT07701928",
"title": "Daridorexant for the Treatment of Sleep Amongst Those With Alcohol Use Disorder Using the Addiction Neuroclinical Assessment Framework",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sterling McPherson",
"sponsor_slug": "sterling-mcpherson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07361549",
"publication_url": "https://clinicaltrials.gov/study/NCT07361549",
"title": "Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial",
"has_exemption": false,
"start_date": "2026-09-09",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel A Tonetti, MD",
"sponsor_slug": "daniel-a-tonetti-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07607860",
"publication_url": "https://clinicaltrials.gov/study/NCT07607860",
"title": "Feasibility Clinical Evaluation of the Adaptilens Accommodating IOL",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adaptilens, Inc.",
"sponsor_slug": "adaptilens-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06689943",
"publication_url": "https://clinicaltrials.gov/study/NCT06689943",
"title": "Pain After Strabismus Surgery: Post-Operative Outcomes Using Courses of Acetaminophen in Children",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ann & Robert H Lurie Children's Hospital of Chicago",
"sponsor_slug": "ann-robert-h-lurie-childrens-hospital-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548113",
"publication_url": "https://clinicaltrials.gov/study/NCT06548113",
"title": "Investigation of Sensory Synchronized Human Brain Imaging and Neuromodulation",
"has_exemption": false,
"start_date": "2026-10-12",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07649070",
"publication_url": "https://clinicaltrials.gov/study/NCT07649070",
"title": "Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas",
"has_exemption": false,
"start_date": "2026-10-12",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07504601",
"publication_url": "https://clinicaltrials.gov/study/NCT07504601",
"title": "Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Center for Complementary and Integrative Health (NCCIH)",
"sponsor_slug": "national-center-for-complementary-and-integrative-health-nccih",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721467",
"publication_url": "https://clinicaltrials.gov/study/NCT07721467",
"title": "Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute on Aging (NIA)",
"sponsor_slug": "national-institute-on-aging-nia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281924",
"publication_url": "https://clinicaltrials.gov/study/NCT07281924",
"title": "A Phase 1b/2 Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of Melphalan Percutaneous Hepatic Perfusion Therapy (HEPZATO KIT™) With Nivolumab and Relatlimab (Opdualag) in Patients With Metastatic Melanoma and Liver Metastasis",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07874490",
"publication_url": "https://clinicaltrials.gov/study/NCT07874490",
"title": "The OCEAN Trial: A Phase II Study of Osimertinib and Cyclosporine to Enhance Antitumor Efficacy in EGFR-Mutant Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07261150",
"publication_url": "https://clinicaltrials.gov/study/NCT07261150",
"title": "Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032701",
"publication_url": "https://clinicaltrials.gov/study/NCT07032701",
"title": "Assessing the Impact of a Disposable Negative Pressure Wound Therapy Device on Surgical Wounds of the Lower Extremities Following Mohs Micrographic Surgery",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07261241",
"publication_url": "https://clinicaltrials.gov/study/NCT07261241",
"title": "NANT 2021-02: A Randomized Phase 2 Study of 131I-MIBG With Vorinostat VS. 131I-MIBG With Dinutuximab vs. 131I-MIBG With Dinutuximab and Vorinostat for Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New Approaches to Neuroblastoma Therapy Consortium",
"sponsor_slug": "new-approaches-to-neuroblastoma-therapy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477418",
"publication_url": "https://clinicaltrials.gov/study/NCT07477418",
"title": "PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP): A Phase Ib/II Open-Label Trial",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Vermont",
"sponsor_slug": "university-of-vermont",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07734155",
"publication_url": "https://clinicaltrials.gov/study/NCT07734155",
"title": "Prospective, Multicenter, Open-label and Non-randomized Trial on Contraceptive Efficacy, Safety and Tolerability of LVS (Levonorgestrel Vaginal System) During 13 Cycles",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chemo Research",
"sponsor_slug": "chemo-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07771361",
"publication_url": "https://clinicaltrials.gov/study/NCT07771361",
"title": "Phase 2 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Luminary Therapeutics",
"sponsor_slug": "luminary-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07782671",
"publication_url": "https://clinicaltrials.gov/study/NCT07782671",
"title": "Nicotinamide Riboside to Improve Functioning in PAD",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07819357",
"publication_url": "https://clinicaltrials.gov/study/NCT07819357",
"title": "A Randomized, Blinded, Within-Subject Trial of Allogeneic Nerve Grafting After Bilateral Nipple-Sparing Mastectomy With Implant-Based Reconstruction",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07836049",
"publication_url": "https://clinicaltrials.gov/study/NCT07836049",
"title": "A Phase II Study of Induction/Window of Opportunity Toripalimab Followed by Definitive Chemoradiotherapy (CRT) and Adjuvant Toripalimab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07359872",
"publication_url": "https://clinicaltrials.gov/study/NCT07359872",
"title": "Relaxin Therapy for Atrial Fibrillation",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deeptankar DeMazumder",
"sponsor_slug": "deeptankar-demazumder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07718984",
"publication_url": "https://clinicaltrials.gov/study/NCT07718984",
"title": "SWIFT-RELIEVE : Simultaneous Treatment of Widespread Pain In Fibromyalgia and PTSD: Randomized Evaluation of Live vs. Inactive Electrical VNS With PE-PC",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554419",
"publication_url": "https://clinicaltrials.gov/study/NCT05554419",
"title": "Eradicating Measurable Residual Disease in Patients With Acute Myeloid Leukemia (AML) Prior to StEm Cell Transplantation (ERASE): A MyeloMATCH Treatment Trial",
"has_exemption": false,
"start_date": "2027-01-04",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07719829",
"publication_url": "https://clinicaltrials.gov/study/NCT07719829",
"title": "Paired VNS For TBI Rehabilitation",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07803692",
"publication_url": "https://clinicaltrials.gov/study/NCT07803692",
"title": "High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06454110",
"publication_url": "https://clinicaltrials.gov/study/NCT06454110",
"title": "A Phase II, Open-Label Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2028-02-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06318403",
"publication_url": "https://clinicaltrials.gov/study/NCT06318403",
"title": "Estradiol Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial",
"has_exemption": false,
"start_date": "2028-03-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05968326",
"publication_url": "https://clinicaltrials.gov/study/NCT05968326",
"title": "A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06179472",
"publication_url": "https://clinicaltrials.gov/study/NCT06179472",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2024-04-14",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Inna Lobeck",
"sponsor_slug": "inna-lobeck",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07068074",
"publication_url": "https://clinicaltrials.gov/study/NCT07068074",
"title": "A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228104",
"publication_url": "https://clinicaltrials.gov/study/NCT07228104",
"title": "Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07499583",
"publication_url": "https://clinicaltrials.gov/study/NCT07499583",
"title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07701941",
"publication_url": "https://clinicaltrials.gov/study/NCT07701941",
"title": "A Phase 1b/2, Multicenter, Open-label, Dose Regimen Determination and Dose Expansion Trial to Evaluate the Safety, Tolerability, Anti-tumor Activity, and an Optimal Dose Regimen of Patritumab Deruxtecan (HER3-DXd) With Trastuzumab Deruxtecan (T-DXd) in Participants With Hormone Receptor Positive, HER2-low or HER2-ultralow, Unresectable or Metastatic Breast Cancer (HERTHENA-Breast02)",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07521657",
"publication_url": "https://clinicaltrials.gov/study/NCT07521657",
"title": "Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07714551",
"publication_url": "https://clinicaltrials.gov/study/NCT07714551",
"title": "A Phase 2 Clinical Trial of Zanzalintinib in Patients With Unresectable and Progressive Metastatic Pheochromocytoma or Paraganglioma (MPPGs)",
"has_exemption": false,
"start_date": "2027-01-09",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07731256",
"publication_url": "https://clinicaltrials.gov/study/NCT07731256",
"title": "A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity",
"has_exemption": false,
"start_date": "2027-02-01",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919939",
"publication_url": "https://clinicaltrials.gov/study/NCT06919939",
"title": "Phase 2 Study of Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2031-01-07",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227610",
"publication_url": "https://clinicaltrials.gov/study/NCT07227610",
"title": "Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2031-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082842",
"publication_url": "https://clinicaltrials.gov/study/NCT07082842",
"title": "A Multicenter, Parallel, Randomized, Placebo (Double-blind) and Pirfenidone (Open-label) Controlled Phase III Clinical Trial Evaluating the Efficacy and Safety of HEC585 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2031-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sunshine Lake Pharma Co., Ltd.",
"sponsor_slug": "sunshine-lake-pharma-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116967",
"publication_url": "https://clinicaltrials.gov/study/NCT07116967",
"title": "A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2031-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06615050",
"publication_url": "https://clinicaltrials.gov/study/NCT06615050",
"title": "A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-02",
"completion_date": "2031-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609239",
"publication_url": "https://clinicaltrials.gov/study/NCT06609239",
"title": "An Open Label Extension Study to Evaluate the Long-term Safety and Efficacy of Subcutaneous Lunsekimig in Adult Participants With Asthma Who Participated in Study DRI16762 or ACT18301",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2031-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07234032",
"publication_url": "https://clinicaltrials.gov/study/NCT07234032",
"title": "A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2031-01-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Insmed Incorporated",
"sponsor_slug": "insmed-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465289",
"publication_url": "https://clinicaltrials.gov/study/NCT07465289",
"title": "A Phase 3, Open-Label, Extension Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-09-16",
"completion_date": "2031-01-23",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03725059",
"publication_url": "https://clinicaltrials.gov/study/NCT03725059",
"title": "A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (KEYNOTE-756)",
"has_exemption": false,
"start_date": "2018-12-27",
"completion_date": "2031-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06667700",
"publication_url": "https://clinicaltrials.gov/study/NCT06667700",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2031-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914908",
"publication_url": "https://clinicaltrials.gov/study/NCT06914908",
"title": "A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2031-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03076658",
"publication_url": "https://clinicaltrials.gov/study/NCT03076658",
"title": "Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers",
"has_exemption": false,
"start_date": "2016-09-30",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06185205",
"publication_url": "https://clinicaltrials.gov/study/NCT06185205",
"title": "Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06313203",
"publication_url": "https://clinicaltrials.gov/study/NCT06313203",
"title": "Trans-arterial Treatment of Patients With Intra-hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oslo University Hospital",
"sponsor_slug": "oslo-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06332534",
"publication_url": "https://clinicaltrials.gov/study/NCT06332534",
"title": "A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Crohn's Disease and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06543576",
"publication_url": "https://clinicaltrials.gov/study/NCT06543576",
"title": "A Prospective Cohort Study of Integrating Radiotherapy Into Chemotherapy With Pembrolizumab and Bevacizumab in Newly Diagnosed Stage IVB Cervical Cancer",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07059091",
"publication_url": "https://clinicaltrials.gov/study/NCT07059091",
"title": "Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)",
"has_exemption": false,
"start_date": "2026-02-12",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318883",
"publication_url": "https://clinicaltrials.gov/study/NCT07318883",
"title": "A Randomized, Double-Blind, Multicenter, Phase II/III Clinical Study to Evaluate HLX07 (Recombinant Anti-EGFR Humanized Monoclonal Antibody Injection) in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Patients With Advanced Squamous Non-Small Cell Lung Cancer (sqNSCLC)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Henlius Biotech",
"sponsor_slug": "shanghai-henlius-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288112",
"publication_url": "https://clinicaltrials.gov/study/NCT07288112",
"title": "Clinical Study of DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diakonos Oncology Corporation",
"sponsor_slug": "diakonos-oncology-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226739",
"publication_url": "https://clinicaltrials.gov/study/NCT07226739",
"title": "Comprehensive Toileting Programming: Enuresis Treatment to a Randomized Clinical Trial of a Caregiver-Mediated Multidisciplinary Intervention for Encopresis",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461584",
"publication_url": "https://clinicaltrials.gov/study/NCT07461584",
"title": "Personalized Memory Enhancement in Aging: Pattern-Optimized tACS With Closed-Loop Precision Modulation",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston University Charles River Campus",
"sponsor_slug": "boston-university-charles-river-campus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07819136",
"publication_url": "https://clinicaltrials.gov/study/NCT07819136",
"title": "A Phase 1 / 2, Open-Label Study of REC-7735 in Participants With Unresectable, Locally Advanced, or Metastatic PIK3CA-H1047R Mutated Solid Tumors",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843641",
"publication_url": "https://clinicaltrials.gov/study/NCT07843641",
"title": "A Phase 2, StrateGIST Legacy Study to Provide Continued Treatment With Velzatinib to Participants With Gastrointestinal Stromal Tumors (GIST) Who Have Completed a Velzatinib Parent Study",
"has_exemption": false,
"start_date": "2026-10-13",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743554",
"publication_url": "https://clinicaltrials.gov/study/NCT07743554",
"title": "Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Girish Dhall, MD",
"sponsor_slug": "girish-dhall-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07862439",
"publication_url": "https://clinicaltrials.gov/study/NCT07862439",
"title": "Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE): A PHASE II TRIAL TO ASSESS THE SAFETY OF BIOMARKER GUIDED IMMUNOSUPPRESSION MINIMIZATION IN LIVER TRANSPLANT RECIPIENTS",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07818070",
"publication_url": "https://clinicaltrials.gov/study/NCT07818070",
"title": "A Phase 3, Randomized, Multicenter, Double-blind Study of the Efficacy and Safety of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With HER2-negative, PD-L1-Positive Advanced or Metastatic Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722598",
"publication_url": "https://clinicaltrials.gov/study/NCT07722598",
"title": "Personalized Memory Enhancement in Aging: Pattern-Optimized tACS With Closed-Loop Precision Modulation",
"has_exemption": false,
"start_date": "2028-05-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston University Charles River Campus",
"sponsor_slug": "boston-university-charles-river-campus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03181867",
"publication_url": "https://clinicaltrials.gov/study/NCT03181867",
"title": "18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer",
"has_exemption": false,
"start_date": "2017-08-03",
"completion_date": "2031-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07527338",
"publication_url": "https://clinicaltrials.gov/study/NCT07527338",
"title": "Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07791225",
"publication_url": "https://clinicaltrials.gov/study/NCT07791225",
"title": "A Bayesian, Operationally Seamless Adaptive Phase 2A/2B, Open-label, Multi-center, Randomized, Two-part Trial to Evaluate the Safety, Efficacy, and Optimal Tidal Volume Distribution of Variable Ventilation (VV) in Participants Undergoing Mechanical Ventilatory Support for Acute Respiratory Distress Syndrome",
"has_exemption": false,
"start_date": "2027-02-01",
"completion_date": "2031-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07493317",
"publication_url": "https://clinicaltrials.gov/study/NCT07493317",
"title": "Neutralizing Interleukin (IL)-6 Signaling to Reverse Immune Related Anhedonia in Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2031-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06312722",
"publication_url": "https://clinicaltrials.gov/study/NCT06312722",
"title": "Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study",
"has_exemption": false,
"start_date": "2024-02-07",
"completion_date": "2031-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Urotronic Inc.",
"sponsor_slug": "urotronic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06401330",
"publication_url": "https://clinicaltrials.gov/study/NCT06401330",
"title": "Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2031-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03418038",
"publication_url": "https://clinicaltrials.gov/study/NCT03418038",
"title": "Phase2 Trial of High Dose Intravenous Ascorbic Acid as an Adjunct to Salvage Chemotherapy in Relapsed/ Refractory Lymphoma, Patients With Clonal Cytopenia of Undetermined Significance, and Chronic Myelomonocytic Leukemia",
"has_exemption": false,
"start_date": "2018-03-23",
"completion_date": "2031-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178808",
"publication_url": "https://clinicaltrials.gov/study/NCT07178808",
"title": "PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER",
"has_exemption": false,
"start_date": "2021-04-16",
"completion_date": "2031-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Banner Health",
"sponsor_slug": "banner-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07862998",
"publication_url": "https://clinicaltrials.gov/study/NCT07862998",
"title": "A Phase 2, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma With FGFR2 Fusion or Rearrangements After at Least 1 Prior Line of Systemic Therapy (FIGHT-214)",
"has_exemption": false,
"start_date": "2026-12-15",
"completion_date": "2031-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06618287",
"publication_url": "https://clinicaltrials.gov/study/NCT06618287",
"title": "A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) Combinations in Adult Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2031-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07832370",
"publication_url": "https://clinicaltrials.gov/study/NCT07832370",
"title": "Phase 1/2 Open-Label Trial With Extended Follow-Up to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Multiple Doses of ALN-6457 in Participants With Symptomatic Prion Disease",
"has_exemption": false,
"start_date": "2026-10-23",
"completion_date": "2031-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04251026",
"publication_url": "https://clinicaltrials.gov/study/NCT04251026",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Participants With Hunter Syndrome",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Denali Therapeutics Inc.",
"sponsor_slug": "denali-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06066580",
"publication_url": "https://clinicaltrials.gov/study/NCT06066580",
"title": "An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety, Biomarkers, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-02",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Edgewise Therapeutics, Inc.",
"sponsor_slug": "edgewise-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06302348",
"publication_url": "https://clinicaltrials.gov/study/NCT06302348",
"title": "A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin",
"has_exemption": false,
"start_date": "2024-03-04",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "PTC Therapeutics",
"sponsor_slug": "ptc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06378866",
"publication_url": "https://clinicaltrials.gov/study/NCT06378866",
"title": "MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06575192",
"publication_url": "https://clinicaltrials.gov/study/NCT06575192",
"title": "A Prospective, Multicenter, Open-Label, Non-Randomized, Controlled Pivotal Study to Evaluate the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix in Implant-Based Two Stage Prepectoral Breast Reconstruction Post-Mastectomy",
"has_exemption": false,
"start_date": "2024-11-05",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07277231",
"publication_url": "https://clinicaltrials.gov/study/NCT07277231",
"title": "A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136415",
"publication_url": "https://clinicaltrials.gov/study/NCT07136415",
"title": "CELESTE: Comparative Effectiveness Study of behavioraL and Drug-rElated inSomnia Therapies for pEri- and Post-menopausal People",
"has_exemption": false,
"start_date": "2026-02-13",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222631",
"publication_url": "https://clinicaltrials.gov/study/NCT07222631",
"title": "An Open-Label, First-in-Human Phase 1/2, Dose-Escalation and Dose-Expansion/ Combination Therapy Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SB-4826 as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas and in Combination With Rituximab in Adult Participants With Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441174",
"publication_url": "https://clinicaltrials.gov/study/NCT07441174",
"title": "A Multicenter, Open-Label, Phase Ib/II Clinical Trial of IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "InxMed (Shanghai) Co., Ltd.",
"sponsor_slug": "inxmed-shanghai-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365995",
"publication_url": "https://clinicaltrials.gov/study/NCT07365995",
"title": "A Phase III, Randomized, Open-label Trial of BNT324 Versus Docetaxel With Prednisone/Prednisolone in Metastatic Castration-resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172256",
"publication_url": "https://clinicaltrials.gov/study/NCT07172256",
"title": "A Pilot Study of CUE-101 in Combination With Pembrolizumab in Subjects With Newly Diagnosed, Locally Advanced HPV-16 Associated Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-05-07",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227350",
"publication_url": "https://clinicaltrials.gov/study/NCT07227350",
"title": "A Phase 2 Controlled Randomized Study of the Efficacy of L19IL2 or L19TNF or L19IL2/L19TNF Intralesional Injections for the Treatment of Locally Advanced Basal Cell Carcinoma (LaBCC)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Philogen S.p.A.",
"sponsor_slug": "philogen-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07673887",
"publication_url": "https://clinicaltrials.gov/study/NCT07673887",
"title": "A Phase 3, Global, Multi-center, Double-blind, Randomized Study of ASP2138 Plus Chemotherapy (CAPOX or mFOLFOX6) With Pembrolizumab vs Placebo Plus Chemotherapy With or Without Pembrolizumab in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma in Participants Whose Tumors Are HER2-negative and Claudin (CLDN) 18.2-positive",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227870",
"publication_url": "https://clinicaltrials.gov/study/NCT07227870",
"title": "A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Basal Cell Carcinoma Patients Progressing or Intolerant to Systemic Treatment.",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Philogen S.p.A.",
"sponsor_slug": "philogen-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228442",
"publication_url": "https://clinicaltrials.gov/study/NCT07228442",
"title": "A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Cutaneous Squamous Cell Carcinoma Patients Progressing on or Intolerant to Systemic Treatment",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Philogen S.p.A.",
"sponsor_slug": "philogen-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07271355",
"publication_url": "https://clinicaltrials.gov/study/NCT07271355",
"title": "Investigation of Mitomycin C PIPAC - FOLFIRI Combination for Unresectable Appendiceal or Colorectal Peritoneal Metastases Treatment (IMPACT): A Multicenter, Randomized, Open-Label, Phase 3 Trial",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07883291",
"publication_url": "https://clinicaltrials.gov/study/NCT07883291",
"title": "SmartEnLite: A Smart Environmental Lighting Intervention to Improve Behaviors and Sleep for Nursing Home Residents Living With Dementia",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Penn State University",
"sponsor_slug": "penn-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07704957",
"publication_url": "https://clinicaltrials.gov/study/NCT07704957",
"title": "A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Tulane University",
"sponsor_slug": "tulane-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05494697",
"publication_url": "https://clinicaltrials.gov/study/NCT05494697",
"title": "A Phase 2 Randomized Open-Label Controlled Study to Evaluate the Efficacy and Safety of Ampligen in Combination With Standard of Care Versus SOC Alone Following First-Line Therapy in Subjects With Locally Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2027-08-31",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AIM ImmunoTech Inc.",
"sponsor_slug": "aim-immunotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05626114",
"publication_url": "https://clinicaltrials.gov/study/NCT05626114",
"title": "A Phase IIa, Multicenter, Open-label, Single-Arm Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2031-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07040280",
"publication_url": "https://clinicaltrials.gov/study/NCT07040280",
"title": "A Phase II Double-Blind Trial of Sulforaphane for Therapeutic Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma",
"has_exemption": false,
"start_date": "2026-02-20",
"completion_date": "2031-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07511023",
"publication_url": "https://clinicaltrials.gov/study/NCT07511023",
"title": "Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2031-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07564401",
"publication_url": "https://clinicaltrials.gov/study/NCT07564401",
"title": "A Phase I/II Open-label Study of DJI136, a DLL3-targeted CAR-T Therapy, in Adult Patients With ES-SCLC",
"has_exemption": false,
"start_date": "2026-06-16",
"completion_date": "2031-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518927",
"publication_url": "https://clinicaltrials.gov/study/NCT07518927",
"title": "Mapping Low-Intensity Focused Ultrasound (LIFU)-Evoked Brain Network Responses Using Intracranial Electrophysiological Recordings",
"has_exemption": false,
"start_date": "2026-03-04",
"completion_date": "2031-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07134088",
"publication_url": "https://clinicaltrials.gov/study/NCT07134088",
"title": "A Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of Administration of Subcutaneous (SC) Blinatumomab in Pediatric Participants With Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2031-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681596",
"publication_url": "https://clinicaltrials.gov/study/NCT07681596",
"title": "A Modular, Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Efficacy of AZD4045, an Allogeneic Chimeric Antigen Receptor-T Cell (CAR-T) Therapy Targeting B Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-07-27",
"completion_date": "2031-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06818643",
"publication_url": "https://clinicaltrials.gov/study/NCT06818643",
"title": "A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2031-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042140",
"publication_url": "https://clinicaltrials.gov/study/NCT06042140",
"title": "Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair: Single Arm Phase III Trial.",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2031-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07863024",
"publication_url": "https://clinicaltrials.gov/study/NCT07863024",
"title": "A Phase 1/2 Study of REGN13089-M404-M2980, a MET-targeting Antibody-Drug Conjugate in Adult Participants With Previously Treated Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-11-23",
"completion_date": "2031-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592924",
"publication_url": "https://clinicaltrials.gov/study/NCT06592924",
"title": "A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2031-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07738978",
"publication_url": "https://clinicaltrials.gov/study/NCT07738978",
"title": "Understanding and Enhancing Human Health and Movement",
"has_exemption": false,
"start_date": "2021-03-21",
"completion_date": "2031-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Louis Stokes VA Medical Center",
"sponsor_slug": "louis-stokes-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616597",
"publication_url": "https://clinicaltrials.gov/study/NCT06616597",
"title": "Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2031-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07795125",
"publication_url": "https://clinicaltrials.gov/study/NCT07795125",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Rimegepant For Endometriosis-Associated Pain",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04746677",
"publication_url": "https://clinicaltrials.gov/study/NCT04746677",
"title": "Single-Center Investigational Device Exemption Trial: Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05180591",
"publication_url": "https://clinicaltrials.gov/study/NCT05180591",
"title": "Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes",
"has_exemption": false,
"start_date": "2022-03-22",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05235165",
"publication_url": "https://clinicaltrials.gov/study/NCT05235165",
"title": "A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05605899",
"publication_url": "https://clinicaltrials.gov/study/NCT05605899",
"title": "An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel Versus Standard of Care Therapy as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-23)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007677",
"publication_url": "https://clinicaltrials.gov/study/NCT06007677",
"title": "A Phase 2 Long-Term Open-Label Trial to Assess the Safety and Efficacy of Repeat Dosing of STAR-0215 in Adult Patients With Hereditary Angioedema (The ALPHA-SOLAR Trial)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839456",
"publication_url": "https://clinicaltrials.gov/study/NCT06839456",
"title": "Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157774",
"publication_url": "https://clinicaltrials.gov/study/NCT07157774",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202598",
"publication_url": "https://clinicaltrials.gov/study/NCT07202598",
"title": "A Phase 2 Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549321",
"publication_url": "https://clinicaltrials.gov/study/NCT07549321",
"title": "A Phase 2/3 Study to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A Treatment Given in Combination With Chemotherapy in Participants With High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Renaissance Pharma Ltd.",
"sponsor_slug": "renaissance-pharma-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303816",
"publication_url": "https://clinicaltrials.gov/study/NCT07303816",
"title": "STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129473",
"publication_url": "https://clinicaltrials.gov/study/NCT07129473",
"title": "Hyperemesis Gravidarum Risk Reduction With Metformin",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07466316",
"publication_url": "https://clinicaltrials.gov/study/NCT07466316",
"title": "A Randomized Phase 3 Study to Compare VAC (Higher Cyclophosphamide Dose and Intensity) Versus VAC/VI (Lower Cyclophosphamide Dose and Intensity) Plus Maintenance Therapy in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma",
"has_exemption": false,
"start_date": "2026-07-14",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07749586",
"publication_url": "https://clinicaltrials.gov/study/NCT07749586",
"title": "A Phase 1/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of ARV-6723 Administered as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arvinas Inc",
"sponsor_slug": "arvinas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346157",
"publication_url": "https://clinicaltrials.gov/study/NCT07346157",
"title": "PNOC044: Liothyronine (L-T3) in Combination With Bevacizumab, Irinotecan and Temozolomide (BIT) for Progressive or Relapsed Medulloblastoma (Cohort 1) or as Monotherapy for Medulloblastoma With Minimal Residual Disease (Cohort 2)",
"has_exemption": false,
"start_date": "2026-08-21",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387305",
"publication_url": "https://clinicaltrials.gov/study/NCT04387305",
"title": "Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): An Efficacy Study",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Nishijima, MD, MAS",
"sponsor_slug": "daniel-nishijima-md-mas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07734701",
"publication_url": "https://clinicaltrials.gov/study/NCT07734701",
"title": "Targeting Neurosteroid Pathways in Alcohol Use Disorder: Clinical and Neural Impact of Pregnenolone Therapy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sherwood Brown, MD, PhD",
"sponsor_slug": "sherwood-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346209",
"publication_url": "https://clinicaltrials.gov/study/NCT07346209",
"title": "STudy of Real-world Individualized Precision-oncology",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845409",
"publication_url": "https://clinicaltrials.gov/study/NCT07845409",
"title": "Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders (TACTIC-BD)",
"has_exemption": false,
"start_date": "2027-06-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785415",
"publication_url": "https://clinicaltrials.gov/study/NCT06785415",
"title": "Phase 1/2 Trial of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07839871",
"publication_url": "https://clinicaltrials.gov/study/NCT07839871",
"title": "A PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE IN CHILDREN AT HIGH RISK OF RSV DISEASE",
"has_exemption": false,
"start_date": "2026-09-28",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227454",
"publication_url": "https://clinicaltrials.gov/study/NCT07227454",
"title": "A Double-blind, Randomized, Psychoactive Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine 84 mg in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder in Adolescent Participants With Acute Suicidal Ideation or Behavior",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2031-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05367440",
"publication_url": "https://clinicaltrials.gov/study/NCT05367440",
"title": "A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)",
"has_exemption": false,
"start_date": "2022-06-02",
"completion_date": "2031-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408259",
"publication_url": "https://clinicaltrials.gov/study/NCT06408259",
"title": "A Phase 3, Multicenter, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2031-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07667478",
"publication_url": "https://clinicaltrials.gov/study/NCT07667478",
"title": "NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2031-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Chi-Ying (Roy) Lin",
"sponsor_slug": "chi-ying-roy-lin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07636564",
"publication_url": "https://clinicaltrials.gov/study/NCT07636564",
"title": "A Phase II Randomized Study of Blinatumomab With or Without Revumenib for Patients With KMT2A-Translocation B-Cell Acute Lymphoblastic Leukemia (ALL)/ Acute Leukemia With Ambiguous Lineage (ALAL) With Persistent Measurable Residual Disease (MRD)",
"has_exemption": false,
"start_date": "2026-10-14",
"completion_date": "2031-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06912698",
"publication_url": "https://clinicaltrials.gov/study/NCT06912698",
"title": "A Phase III Randomized Controlled Non-Inferiority Clinical Trial Comparing Reduced-Dose Versus Standard-Dose Radiotherapy Based on Treatment Response in Early-Stage Nasopharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2031-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Hai-Qiang Mai,MD,PhD",
"sponsor_slug": "hai-qiang-maimdphd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05675410",
"publication_url": "https://clinicaltrials.gov/study/NCT05675410",
"title": "A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2031-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679101",
"publication_url": "https://clinicaltrials.gov/study/NCT06679101",
"title": "A Phase 3, Randomized, Open-label Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2031-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335876",
"publication_url": "https://clinicaltrials.gov/study/NCT05335876",
"title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2031-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01958086",
"publication_url": "https://clinicaltrials.gov/study/NCT01958086",
"title": "Visuomotor Prosthetic for Paralysis",
"has_exemption": false,
"start_date": "2013-10-01",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Richard A. Andersen, PhD",
"sponsor_slug": "richard-a-andersen-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05552222",
"publication_url": "https://clinicaltrials.gov/study/NCT05552222",
"title": "A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy",
"has_exemption": false,
"start_date": "2022-10-25",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06149286",
"publication_url": "https://clinicaltrials.gov/study/NCT06149286",
"title": "A Phase 3, Open Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Combination With Lenalidomide Versus Rituximab in Combination With Lenalidomide in Relapsed/Refractory Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06750185",
"publication_url": "https://clinicaltrials.gov/study/NCT06750185",
"title": "A Phase I/II, First-in-human, Open-label Trial of the Safety, Efficacy, Tolerability, Pharmacokinetics, and Immunogenicity of BNT317 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-01-13",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799195",
"publication_url": "https://clinicaltrials.gov/study/NCT06799195",
"title": "A Phase II Randomized Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Older Adults With Hematological Malignancies: the PROMISE Trial",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07558759",
"publication_url": "https://clinicaltrials.gov/study/NCT07558759",
"title": "Temporal Interference in Psychiatry (TIP): Neuromodulation Using Temporal Interference",
"has_exemption": false,
"start_date": "2026-04-07",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227285",
"publication_url": "https://clinicaltrials.gov/study/NCT07227285",
"title": "Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy Expressing a Transgene Encoding the Light Chain of Botulinum Toxin F",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cyllene Therapeutics",
"sponsor_slug": "cyllene-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387549",
"publication_url": "https://clinicaltrials.gov/study/NCT07387549",
"title": "A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis",
"has_exemption": false,
"start_date": "2026-05-14",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021937",
"publication_url": "https://clinicaltrials.gov/study/NCT07021937",
"title": "Investigating Brain PLASTICity and GLP-1 Receptor Agonists in the Treatment of Obesity: The PLASTIC Trial",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332182",
"publication_url": "https://clinicaltrials.gov/study/NCT07332182",
"title": "Multicenter Prospective Randomized Study of MaioRegenTM Prime vs. Debridement (Surgical Standard of Care (SSOC)) for the Treatment of Osteochondral Lesion of the Knee Joint - OSTEOCONFIRM Study",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fin-Ceramica Faenza Spa",
"sponsor_slug": "fin-ceramica-faenza-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964230",
"publication_url": "https://clinicaltrials.gov/study/NCT06964230",
"title": "A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-26",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "T3D Therapeutics, Inc.",
"sponsor_slug": "t3d-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101666",
"publication_url": "https://clinicaltrials.gov/study/NCT07101666",
"title": "Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07715734",
"publication_url": "https://clinicaltrials.gov/study/NCT07715734",
"title": "A Phase 2 Study of Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma (CONTRAC-2)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07485010",
"publication_url": "https://clinicaltrials.gov/study/NCT07485010",
"title": "A Multi-centre, Randomised Trial Comparing a Novel Combination Treatment (Arm D - Intravenous Sulbactam-durlobactam in Combination With Intravenous Ceftriaxone, Oral Amoxicillin, Oral Azithromycin and Oral Clofazimine) Versus Standard of Care Treatments for the Intensive Phase of Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial",
"has_exemption": false,
"start_date": "2027-04-30",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Queensland",
"sponsor_slug": "the-university-of-queensland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07840352",
"publication_url": "https://clinicaltrials.gov/study/NCT07840352",
"title": "A Phase 4, Cluster-Randomized Crossover, Prospective, Multi-Center Trial Evaluating the Safety of Freeze-Dried Plasma and Conventional Plasma Products in Adult Patients",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Teleflex",
"sponsor_slug": "teleflex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05991388",
"publication_url": "https://clinicaltrials.gov/study/NCT05991388",
"title": "A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-05-02",
"completion_date": "2031-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Birmingham",
"sponsor_slug": "university-of-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07457385",
"publication_url": "https://clinicaltrials.gov/study/NCT07457385",
"title": "Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs. Benzathine in Neonates With Possible Congenital Syphilis",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288359",
"publication_url": "https://clinicaltrials.gov/study/NCT07288359",
"title": "An Open-label, Multi-center, Phase I/II Study of GVV858 as a Single Agent and in Combination With Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2- Negative Breast Cancer and Other Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2031-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07468903",
"publication_url": "https://clinicaltrials.gov/study/NCT07468903",
"title": "Phase II Trial of Focal Radiation Therapy in Patients With Prostate Cancer",
"has_exemption": false,
"start_date": "2026-05-11",
"completion_date": "2031-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07497607",
"publication_url": "https://clinicaltrials.gov/study/NCT07497607",
"title": "Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (REDUCE-30)",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2031-05-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sara Medek",
"sponsor_slug": "sara-medek",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06674577",
"publication_url": "https://clinicaltrials.gov/study/NCT06674577",
"title": "A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2031-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Vera Therapeutics, Inc.",
"sponsor_slug": "vera-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710626",
"publication_url": "https://clinicaltrials.gov/study/NCT06710626",
"title": "CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2031-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07613099",
"publication_url": "https://clinicaltrials.gov/study/NCT07613099",
"title": "Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET/CT Imaging)",
"has_exemption": false,
"start_date": "2026-09-18",
"completion_date": "2031-05-26",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910813",
"publication_url": "https://clinicaltrials.gov/study/NCT06910813",
"title": "An Open-label, Multi-center, Phase I/II Study to Assess Safety, Tolerability and Efficacy of DFT383 in Pediatric Participants With Nephropathic Cystinosis, Followed by a Long-term Extension Phase",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2031-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05561387",
"publication_url": "https://clinicaltrials.gov/study/NCT05561387",
"title": "A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of \"Intermediate Fit\" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919003",
"publication_url": "https://clinicaltrials.gov/study/NCT06919003",
"title": "Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (RTB-021)",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07650188",
"publication_url": "https://clinicaltrials.gov/study/NCT07650188",
"title": "Stimulating the Aging Brain: Noninvasive Brain and Sensory Stimulation Strategies in Aging",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07650643",
"publication_url": "https://clinicaltrials.gov/study/NCT07650643",
"title": "EEG Biomarkers for Pediatric ADHD Treatment Stratification",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07711002",
"publication_url": "https://clinicaltrials.gov/study/NCT07711002",
"title": "A Randomized, Double-Blind, Placebo-Controlled, 2-Cohort, Phase III Study of Saruparib Combined With Physician's Choice of Androgen Receptor Pathway Inhibitor in Patients With Metastatic Hormone-Sensitive Prostate Cancer, Previously Treated With Docetaxel or PSMA-directed 177Lutetium-Containing Therapy Without Disease Progression, and With Prostate-Specific Antigen ≥ 0.2 ng/mL: EvoPAR-Prostate05",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07662928",
"publication_url": "https://clinicaltrials.gov/study/NCT07662928",
"title": "Epcoritamab in Combination With Dose Adjusted R-EPOCH for High Risk Burkitt Lymphoma (BL) (BEDROCK Study)",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AIDS Malignancy Consortium",
"sponsor_slug": "aids-malignancy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03314181",
"publication_url": "https://clinicaltrials.gov/study/NCT03314181",
"title": "A Phase 1/2, Multicenter, Dose-Escalation and Expansion Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Subjects With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2018-04-02",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923958",
"publication_url": "https://clinicaltrials.gov/study/NCT04923958",
"title": "Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) Study",
"has_exemption": false,
"start_date": "2021-04-14",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05856370",
"publication_url": "https://clinicaltrials.gov/study/NCT05856370",
"title": "The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Spinal and Biologics",
"sponsor_slug": "medtronic-spinal-and-biologics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866536",
"publication_url": "https://clinicaltrials.gov/study/NCT05866536",
"title": "Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years",
"has_exemption": false,
"start_date": "2023-05-04",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086755",
"publication_url": "https://clinicaltrials.gov/study/NCT07086755",
"title": "Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul Potnuru",
"sponsor_slug": "paul-potnuru",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07543120",
"publication_url": "https://clinicaltrials.gov/study/NCT07543120",
"title": "A Multicenter Open-label Extension Study to Evaluate Long-term Safety and Efficacy of QCZ484 in Hypertensive Patients.",
"has_exemption": false,
"start_date": "2026-05-07",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07479797",
"publication_url": "https://clinicaltrials.gov/study/NCT07479797",
"title": "A Phase 3, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428148",
"publication_url": "https://clinicaltrials.gov/study/NCT07428148",
"title": "Phase I/II Trial of Induction Lattice-Based Radiotherapy and Chemoimmunotherapy Preceding Response-Adapted Definitive Chemoradiation for Non-Low Risk Oropharyngeal Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07636785",
"publication_url": "https://clinicaltrials.gov/study/NCT07636785",
"title": "A Phase 1 and 2 First-in-human, Open-label, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of VMD-102 in Participants With Hepatocellular Carcinoma and Other Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VM Discovery, Inc.",
"sponsor_slug": "vm-discovery-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07607665",
"publication_url": "https://clinicaltrials.gov/study/NCT07607665",
"title": "Paired Stimulation of Hand Motor Cortex and Median Nerve to Induce Spinal Cord Plasticity in Hemiplegic Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-07-27",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07758660",
"publication_url": "https://clinicaltrials.gov/study/NCT07758660",
"title": "Alzheimer's Disease Research Center PET Component",
"has_exemption": false,
"start_date": "2026-08-06",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Lao",
"sponsor_slug": "patrick-lao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278362",
"publication_url": "https://clinicaltrials.gov/study/NCT07278362",
"title": "Safety of Intramuscular Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07704385",
"publication_url": "https://clinicaltrials.gov/study/NCT07704385",
"title": "Enhancing Rehabilitation in Aging Study (ERAS)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07472322",
"publication_url": "https://clinicaltrials.gov/study/NCT07472322",
"title": "UW26001 Phase I/II Study on the Safety, Tolerability, and Preliminary Efficacy of ASTX727 (Decitabine/Cedazuridine) and Retifanlimab-dlwr in Patients With Advanced Merkel Cell Carcinoma Who Have Progressed on Anti-PD-(L)1 Inhibitor",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07795593",
"publication_url": "https://clinicaltrials.gov/study/NCT07795593",
"title": "Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy (MCPAIN)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623187",
"publication_url": "https://clinicaltrials.gov/study/NCT07623187",
"title": "A Two-part, Phase 2b/Phase 3 Double-blinded, Randomized Study of IPN60340 in Combination With Azacitidine and Venetoclax Versus Placebo in Combination With Azacitidine and Venetoclax in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07620548",
"publication_url": "https://clinicaltrials.gov/study/NCT07620548",
"title": "A Randomized Phase II Study of the Efficacy of Laser Interstitial Thermal Therapy (LiTT) Combined With Cemiplimab Versus Physician's Choice Chemotherapy in Recurrent Glioblastomas",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166393",
"publication_url": "https://clinicaltrials.gov/study/NCT07166393",
"title": "Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2027-05-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167953",
"publication_url": "https://clinicaltrials.gov/study/NCT07167953",
"title": "MRI Technology for Greater Efficiency and Improved Value",
"has_exemption": false,
"start_date": "2028-08-31",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02375204",
"publication_url": "https://clinicaltrials.gov/study/NCT02375204",
"title": "A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors",
"has_exemption": false,
"start_date": "2015-08-06",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05317858",
"publication_url": "https://clinicaltrials.gov/study/NCT05317858",
"title": "A Randomized Pivotal Study Assessing the Safety and Efficacy of Targeted Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound During the Standard of Care Treatment of Brain Metastases of Non-small Cell Lung Cancer (NSCLC) Origin",
"has_exemption": false,
"start_date": "2022-08-12",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "InSightec",
"sponsor_slug": "insightec",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06967610",
"publication_url": "https://clinicaltrials.gov/study/NCT06967610",
"title": "Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07547917",
"publication_url": "https://clinicaltrials.gov/study/NCT07547917",
"title": "Improving the Measurement of Neonatal High Blood Pressure Using the Boppli Device",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321912",
"publication_url": "https://clinicaltrials.gov/study/NCT07321912",
"title": "A Phase II Open Label Basket Trial Study Using Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158567",
"publication_url": "https://clinicaltrials.gov/study/NCT07158567",
"title": "Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low Back PaiN Treatment: VIBRANT",
"has_exemption": false,
"start_date": "2026-10-14",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415772",
"publication_url": "https://clinicaltrials.gov/study/NCT07415772",
"title": "The Effect of Right dlPFC cTBS on Acute Measures of Anxiety, Functional Connectivity, and TMS-evoked BOLD Responses.",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07503782",
"publication_url": "https://clinicaltrials.gov/study/NCT07503782",
"title": "Investigating Oleoylethanolamide (OEA) as a Novel Multi-System Based Therapeutic for Young Adults With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07762365",
"publication_url": "https://clinicaltrials.gov/study/NCT07762365",
"title": "A Study of Transcranial Electrical Stimulation (tES) Paired With Structured Learning Protocols for Accelerated Skill Acquisition: Sub-Protocol B (Pediatric Reading Support for Children With Dyslexia and Reading Disabilities)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "General Neuro Inc.",
"sponsor_slug": "general-neuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07788755",
"publication_url": "https://clinicaltrials.gov/study/NCT07788755",
"title": "NEUROmetabolic Mechanisms of COGnitive Training in Schizophrenia",
"has_exemption": false,
"start_date": "2026-11-02",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07819396",
"publication_url": "https://clinicaltrials.gov/study/NCT07819396",
"title": "A Phase II Prospective Study Evaluating Selective Depletion of CD45RA⁺ Naïve T Cells (TND) From Peripheral Blood Stem Cell Grafts for the Prevention of Graft-Versus-Host Disease in Older Patients With Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07340541",
"publication_url": "https://clinicaltrials.gov/study/NCT07340541",
"title": "TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE-BDT)",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2031-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07604233",
"publication_url": "https://clinicaltrials.gov/study/NCT07604233",
"title": "Phase I/II of the Combination of Fludarabine, Cytarabine, Idarubicin, G-CSF (FLAG-Ida) With Venetoclax and Asciminib in Patients With Advanced Phase Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2031-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04657822",
"publication_url": "https://clinicaltrials.gov/study/NCT04657822",
"title": "An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2031-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222553",
"publication_url": "https://clinicaltrials.gov/study/NCT07222553",
"title": "Open-label, Uncontrolled, Multicenter Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Immunoglobulin G4-related Disease (IgG4-RD)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05769777",
"publication_url": "https://clinicaltrials.gov/study/NCT05769777",
"title": "An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2031-06-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02065011",
"publication_url": "https://clinicaltrials.gov/study/NCT02065011",
"title": "An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B",
"has_exemption": false,
"start_date": "2013-09-12",
"completion_date": "2031-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06482684",
"publication_url": "https://clinicaltrials.gov/study/NCT06482684",
"title": "Early Treatment Intensification in Patients With High Risk Mantle Cell Lymphoma Using CAR-T-cell Treatment After an Abbreviated Induction Therapy With Rituximab and Ibrutinib and 6 Months Ibrutinib Maintenance (Arm A) as Compared to Standard of Care Induction and Maintenance (Arm B)",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2031-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Christian Schmidt, MD",
"sponsor_slug": "christian-schmidt-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07646678",
"publication_url": "https://clinicaltrials.gov/study/NCT07646678",
"title": "A Long-term Extension Trial to Evaluate the Safety and Tolerability of TAK-360 in Participants With Selected Central Hypersomnia Conditions",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2031-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06763328",
"publication_url": "https://clinicaltrials.gov/study/NCT06763328",
"title": "Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer",
"has_exemption": false,
"start_date": "2025-01-13",
"completion_date": "2031-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05805826",
"publication_url": "https://clinicaltrials.gov/study/NCT05805826",
"title": "A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND IMMUNOPERSISTENCE OF A CLOSTRIDIOIDES DIFFICILE VACCINE ADMINISTERED WITH NOVEL ADJUVANTS IN HEALTHY ADULTS",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2031-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06363994",
"publication_url": "https://clinicaltrials.gov/study/NCT06363994",
"title": "A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study of Orelabrutinib in Combination with Rituximab and Bendamustine (BR) Vs. BR in Subjects with Treatment-Naїve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "InnoCare Pharma Inc.",
"sponsor_slug": "innocare-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858319",
"publication_url": "https://clinicaltrials.gov/study/NCT06858319",
"title": "A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134375",
"publication_url": "https://clinicaltrials.gov/study/NCT06134375",
"title": "Novel Targeting of the Microenvironment to Decrease Metastatic Recurrence of High-Risk TNBC: A Randomized Phase II Study of Tetrathiomolybdate (TM) Plus Capecitabine in Patients With Breast Cancer at High Risk of Recurrence",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2031-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01000350",
"publication_url": "https://clinicaltrials.gov/study/NCT01000350",
"title": "Intravenous Saline on Exercise Tolerance in Orthostatic Intolerance",
"has_exemption": false,
"start_date": "2009-10-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01419067",
"publication_url": "https://clinicaltrials.gov/study/NCT01419067",
"title": "A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection",
"has_exemption": false,
"start_date": "2011-08-22",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03424018",
"publication_url": "https://clinicaltrials.gov/study/NCT03424018",
"title": "A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923126",
"publication_url": "https://clinicaltrials.gov/study/NCT04923126",
"title": "SJ901: Phase 1/2 Evaluation of Single Agent Mirdametinib (PD-0325901), a Brain-Penetrant MEK1/2 Inhibitor, for the Treatment of Children, Adolescents, and Young Adults With Low-Grade Glioma",
"has_exemption": false,
"start_date": "2021-06-21",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05296447",
"publication_url": "https://clinicaltrials.gov/study/NCT05296447",
"title": "A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Diabetic Retinopathy With and Without Center Involved-Diabetic Macular Edema",
"has_exemption": false,
"start_date": "2022-04-04",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05606614",
"publication_url": "https://clinicaltrials.gov/study/NCT05606614",
"title": "An Open-label Phase 1/2/3 Study Consisting of a Phase 1/2 Safety and Dose-escalation and Phase 3 Dose-expansion Study to Evaluate Safety and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy in Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06278870",
"publication_url": "https://clinicaltrials.gov/study/NCT06278870",
"title": "Disitamab Vedotin in Combination With Pyrotinib Versus THP in the First-line Treatment for HER2-positive Advanced Breast Cancer, a Multicentre, Randomized, Double-blind Controlled, Phase III Trial",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
"sponsor_slug": "sun-yat-sen-memorial-hospital-of-sun-yat-sen-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204938",
"publication_url": "https://clinicaltrials.gov/study/NCT07204938",
"title": "A Phase 3 Trial to Evaluate the Long-Term Safety and Efficacy of Navenibart in Participants With Hereditary Angioedema - ORBIT-EXPANSE",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07462507",
"publication_url": "https://clinicaltrials.gov/study/NCT07462507",
"title": "Investigation of Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07660614",
"publication_url": "https://clinicaltrials.gov/study/NCT07660614",
"title": "A First-in-Human, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intrathecally Administered LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leal Therapeutics, Inc",
"sponsor_slug": "leal-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07490301",
"publication_url": "https://clinicaltrials.gov/study/NCT07490301",
"title": "Phase 2/3 Open Label Randomized Study of Telisotuzumab Adizutecan in Combination With FOLFOX Compared to Standard of Care in Subjects With First-Line Metastatic Pancreatic Ductal Adenocarcinoma - AndroMETa-PDAC-288",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07480564",
"publication_url": "https://clinicaltrials.gov/study/NCT07480564",
"title": "ASPIRE Study: A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females Aged >2 to <4 Years With Rett Syndrome",
"has_exemption": false,
"start_date": "2026-05-08",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325487",
"publication_url": "https://clinicaltrials.gov/study/NCT07325487",
"title": "Adaptive Deep Brain Stimulation Targeting the Interposed Nucleus to Treat Spinocerebellar Ataxia",
"has_exemption": false,
"start_date": "2026-06-02",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07630649",
"publication_url": "https://clinicaltrials.gov/study/NCT07630649",
"title": "Evaluation of the Safety and Tolerability of Ixoberogene Soroparvovec (Ixo-vec) Intravitreal Gene Therapy in the Second (Contralateral) Eye of Participants With Bilateral Neovascular Age-related Macular Degeneration.",
"has_exemption": false,
"start_date": "2026-06-02",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Adverum Biotechnologies, Inc.",
"sponsor_slug": "adverum-biotechnologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07582120",
"publication_url": "https://clinicaltrials.gov/study/NCT07582120",
"title": "A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325149",
"publication_url": "https://clinicaltrials.gov/study/NCT07325149",
"title": "Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052956",
"publication_url": "https://clinicaltrials.gov/study/NCT06052956",
"title": "A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07329153",
"publication_url": "https://clinicaltrials.gov/study/NCT07329153",
"title": "Neuronavigated and Non-Neuronavigated Accelerated Intermittent Theta-Burst Stimulation for Treatment-Resistant Depression A Sham-Controlled Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222046",
"publication_url": "https://clinicaltrials.gov/study/NCT07222046",
"title": "Identifying Residual Connectivity in Veterans With Spinal Cord Injury for Precision Neurorehabilitation",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07685886",
"publication_url": "https://clinicaltrials.gov/study/NCT07685886",
"title": "MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07735819",
"publication_url": "https://clinicaltrials.gov/study/NCT07735819",
"title": "Tryptophan-kynurenine Pathway PET Imaging in Human Gliomas",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Barbara Ann Karmanos Cancer Institute",
"sponsor_slug": "barbara-ann-karmanos-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767006",
"publication_url": "https://clinicaltrials.gov/study/NCT07767006",
"title": "Neuromodulation for the Treatment of Postural Instability in Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Felipe Fregni, MD, PhD, MPH",
"sponsor_slug": "felipe-fregni-md-phd-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07138274",
"publication_url": "https://clinicaltrials.gov/study/NCT07138274",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Metyrapone in Subjects Diagnosed With Mild Autonomous Cortisol Secretion (MACS)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07699237",
"publication_url": "https://clinicaltrials.gov/study/NCT07699237",
"title": "REPLAT- A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Cologne",
"sponsor_slug": "university-of-cologne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07738874",
"publication_url": "https://clinicaltrials.gov/study/NCT07738874",
"title": "Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 3 (BabySTEPS3)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07635056",
"publication_url": "https://clinicaltrials.gov/study/NCT07635056",
"title": "Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07781891",
"publication_url": "https://clinicaltrials.gov/study/NCT07781891",
"title": "Rapid Advancement Of Promising Innovative Drugs (RAPID): A Patient-Centric, Investigator-Initiated, Bayesian, Multi-Center, Open-Label, Phase 2 Platform Trial Of Promising Drugs For AYA Patients With Relapsed/Refractory Ewing Sarcoma & DSRCT",
"has_exemption": false,
"start_date": "2027-02-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449299",
"publication_url": "https://clinicaltrials.gov/study/NCT07449299",
"title": "Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07838597",
"publication_url": "https://clinicaltrials.gov/study/NCT07838597",
"title": "The Emmetropization Via Accommodation (EVA) - II Study",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699966",
"publication_url": "https://clinicaltrials.gov/study/NCT06699966",
"title": "Stony Brook Medicine Anti-Inflammatory Trial",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06545695",
"publication_url": "https://clinicaltrials.gov/study/NCT06545695",
"title": "Epidermal Growth Factor Receptor Inhibition for Keratinopathies",
"has_exemption": false,
"start_date": "2027-07-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548061",
"publication_url": "https://clinicaltrials.gov/study/NCT06548061",
"title": "Single Center Observational Study Using Spinal Laser Interstitial Thermal Therapy (sLITT) in the Treatment of Spine Metastases and Tumors",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04990921",
"publication_url": "https://clinicaltrials.gov/study/NCT04990921",
"title": "A Phase 2 Study of Palliative Radiation in Combination with Pembrolizumab in Subjects with Unresectable Metastatic Stage IV Breast Cancer: Twisted Pink",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05027945",
"publication_url": "https://clinicaltrials.gov/study/NCT05027945",
"title": "A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome",
"has_exemption": false,
"start_date": "2023-02-23",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06040970",
"publication_url": "https://clinicaltrials.gov/study/NCT06040970",
"title": "A Single-Center, Open-Label, Single-Arm, Phase I Study With Dose Expansion Cohort of Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07508995",
"publication_url": "https://clinicaltrials.gov/study/NCT07508995",
"title": "A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)",
"has_exemption": false,
"start_date": "2026-08-20",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07825857",
"publication_url": "https://clinicaltrials.gov/study/NCT07825857",
"title": "Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929664",
"publication_url": "https://clinicaltrials.gov/study/NCT05929664",
"title": "Neoadjuvant REGN2810 (Cemiplimab) or REGN2810 (Cemiplimab) Plus REGN3767 (Fianlimab) in Cutaneous Basal Cell Carcinoma of the Head and Neck",
"has_exemption": false,
"start_date": "2023-07-05",
"completion_date": "2031-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232602",
"publication_url": "https://clinicaltrials.gov/study/NCT07232602",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents in Combination With Enfortumab Vedotin Plus Pembrolizumab as First-Line Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma: KEYMAKER-U04-Substudy 04D",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2031-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07493304",
"publication_url": "https://clinicaltrials.gov/study/NCT07493304",
"title": "A 2-Part, Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against Factor XI, for the Treatment and Secondary Prevention of Venous Thromboembolism in Participants With Solid and Hematologic Cancers (ROXI-CAT-II)",
"has_exemption": false,
"start_date": "2026-08-26",
"completion_date": "2031-07-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392892",
"publication_url": "https://clinicaltrials.gov/study/NCT07392892",
"title": "A PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA",
"has_exemption": false,
"start_date": "2026-05-14",
"completion_date": "2031-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793409",
"publication_url": "https://clinicaltrials.gov/study/NCT07793409",
"title": "An Extension Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig, Including Inhaled Corticosteroid Withdrawal, in Adults With Chronic Obstructive Pulmonary Disease (COPD) Who Completed Studies EFC18243 or EFC18244",
"has_exemption": false,
"start_date": "2026-09-16",
"completion_date": "2031-07-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06538337",
"publication_url": "https://clinicaltrials.gov/study/NCT06538337",
"title": "Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers (HERA Trial)",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2031-07-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07850921",
"publication_url": "https://clinicaltrials.gov/study/NCT07850921",
"title": "Phase 1/2 Trial of REGN21353 (a STEAP1xCD3 Bispecific Antibody) Administered Alone or in Combination With Nezastomig (a PSMAxCD28 Bispecific Antibody) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2027-06-28",
"completion_date": "2031-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06144606",
"publication_url": "https://clinicaltrials.gov/study/NCT06144606",
"title": "Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2031-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698796",
"publication_url": "https://clinicaltrials.gov/study/NCT06698796",
"title": "A PHASE 3, MULTI-CENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF DAZUKIBART IN PARTICIPANTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH DERMATOMYOSITIS OR POLYMYOSITIS)",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2031-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07769047",
"publication_url": "https://clinicaltrials.gov/study/NCT07769047",
"title": "Breast Cancer Survivors With Obesity - Semaglutide's Impact on Preclinical Markers of Cardiovascular Disease",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2031-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07598825",
"publication_url": "https://clinicaltrials.gov/study/NCT07598825",
"title": "A Phase 2/3, Randomized, Double-blind, Multicenter, Placebo-controlled Study of Inebilizumab in Participants With Autoimmune Hepatitis",
"has_exemption": false,
"start_date": "2026-10-13",
"completion_date": "2031-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03773965",
"publication_url": "https://clinicaltrials.gov/study/NCT03773965",
"title": "A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)",
"has_exemption": false,
"start_date": "2019-04-05",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05210803",
"publication_url": "https://clinicaltrials.gov/study/NCT05210803",
"title": "A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Participants With Neovascular Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2021-12-20",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05905926",
"publication_url": "https://clinicaltrials.gov/study/NCT05905926",
"title": "An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 6 to Less Than 18 Years Old",
"has_exemption": false,
"start_date": "2023-02-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ardelyx",
"sponsor_slug": "ardelyx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864534",
"publication_url": "https://clinicaltrials.gov/study/NCT05864534",
"title": "A Phase 2a Trial of Immune Modulation in Combination With Ultrasound-mediated Blood Brain Barrier Opening in Patients With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06641271",
"publication_url": "https://clinicaltrials.gov/study/NCT06641271",
"title": "Vagus Nerve Stimulation to Promote Remyelination in Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789913",
"publication_url": "https://clinicaltrials.gov/study/NCT06789913",
"title": "A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899152",
"publication_url": "https://clinicaltrials.gov/study/NCT06899152",
"title": "HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948786",
"publication_url": "https://clinicaltrials.gov/study/NCT06948786",
"title": "PROMOTE-FL: Pirtobrutinib and Mosunetuzumab to Enhance Treatment Efficacy for Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128381",
"publication_url": "https://clinicaltrials.gov/study/NCT07128381",
"title": "Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222137",
"publication_url": "https://clinicaltrials.gov/study/NCT07222137",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Baricitinib to Delay Stage 3 Type 1 Diabetes in At-risk Participants Aged ≥1 to <36 Years",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232069",
"publication_url": "https://clinicaltrials.gov/study/NCT07232069",
"title": "Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis",
"has_exemption": false,
"start_date": "2026-07-21",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07655440",
"publication_url": "https://clinicaltrials.gov/study/NCT07655440",
"title": "Comparative Outcomes of Migraine Preventives and Anti-CGRP Therapies for Tinnitus in Patients With Migraine: A Randomized Active-Comparator Controlled Trial (COMPACT-PM)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07661498",
"publication_url": "https://clinicaltrials.gov/study/NCT07661498",
"title": "Indomethacin vs. no Indomethacin for Patients Undergoing Biliary ERCP With Prior Biliary Sphincterotomy",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07673367",
"publication_url": "https://clinicaltrials.gov/study/NCT07673367",
"title": "A Phase 2 Trial of Nemtabrutinib in Combination With Brexu-cel for Patients With Relapsed/Refractory Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602166",
"publication_url": "https://clinicaltrials.gov/study/NCT07602166",
"title": "Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845604",
"publication_url": "https://clinicaltrials.gov/study/NCT07845604",
"title": "An Precision Immunopsychiatric Pharmacological Probe of Adalimumab as an Anti-depressant",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Moriarity",
"sponsor_slug": "daniel-moriarity",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07815691",
"publication_url": "https://clinicaltrials.gov/study/NCT07815691",
"title": "The Contribution of the Endocannabinoid System to Sex Differences in THC-associated Reward",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07859293",
"publication_url": "https://clinicaltrials.gov/study/NCT07859293",
"title": "Interventional, Open-label, Extension Trial of Asedebart (Lu AG13909) in Participants With Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174414",
"publication_url": "https://clinicaltrials.gov/study/NCT07174414",
"title": "Cilostazol for Prevention of Recurrent Stroke Trial",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07729332",
"publication_url": "https://clinicaltrials.gov/study/NCT07729332",
"title": "Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1-based Therapy Discontinuation",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07775339",
"publication_url": "https://clinicaltrials.gov/study/NCT07775339",
"title": "Open Label Phase 3b Study to Evaluate the Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents, 6 to 17 Years of Age, With Heterozygous Familial Hypercholesterolemia (LIBerate-Kids OLE)",
"has_exemption": false,
"start_date": "2027-01-20",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "LIB Therapeutics LLC",
"sponsor_slug": "lib-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07798232",
"publication_url": "https://clinicaltrials.gov/study/NCT07798232",
"title": "Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children",
"has_exemption": false,
"start_date": "2027-02-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07506512",
"publication_url": "https://clinicaltrials.gov/study/NCT07506512",
"title": "Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss",
"has_exemption": false,
"start_date": "2027-07-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07796308",
"publication_url": "https://clinicaltrials.gov/study/NCT07796308",
"title": "Terazosin And Metabolic Engagement in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2027-08-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qiang Zhang",
"sponsor_slug": "qiang-zhang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07408583",
"publication_url": "https://clinicaltrials.gov/study/NCT07408583",
"title": "A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses",
"has_exemption": false,
"start_date": "2028-01-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agnieszka Czechowicz",
"sponsor_slug": "agnieszka-czechowicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866262",
"publication_url": "https://clinicaltrials.gov/study/NCT06866262",
"title": "Phase I/II Trial of Inulin Gel in Combination With Ipilimumab and Nivolumab in Advanced Renal Cell Carcinoma [ICON Trial]",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07063745",
"publication_url": "https://clinicaltrials.gov/study/NCT07063745",
"title": "A Randomized Phase 2/3 Study of Navlimetostat (BMS-986504) in Combination With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2031-08-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568172",
"publication_url": "https://clinicaltrials.gov/study/NCT06568172",
"title": "Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2031-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07764718",
"publication_url": "https://clinicaltrials.gov/study/NCT07764718",
"title": "Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy",
"has_exemption": false,
"start_date": "2026-09-16",
"completion_date": "2031-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940297",
"publication_url": "https://clinicaltrials.gov/study/NCT06940297",
"title": "DART: Phase II Study of Dasatinib and Quercetin in Patients With Relapsed, Refractory Multiple Myeloma Receiving CAR-T Therapy",
"has_exemption": false,
"start_date": "2025-09-18",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07630974",
"publication_url": "https://clinicaltrials.gov/study/NCT07630974",
"title": "LIGHTBEAM-U01 Substudy 01D: A Phase 1b/2 Substudy to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2026-07-06",
"completion_date": "2031-08-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07753954",
"publication_url": "https://clinicaltrials.gov/study/NCT07753954",
"title": "Imaging to Re-evaluate Elacestrant Clinical Application",
"has_exemption": false,
"start_date": "2026-09-13",
"completion_date": "2031-08-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Jules Bordet Institute",
"sponsor_slug": "jules-bordet-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346196",
"publication_url": "https://clinicaltrials.gov/study/NCT07346196",
"title": "A Randomized Phase II Trial of Induction Cemiplimab Plus Chemotherapy With or Without Fianlimab in Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck",
"has_exemption": false,
"start_date": "2027-02-07",
"completion_date": "2031-08-22",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05285891",
"publication_url": "https://clinicaltrials.gov/study/NCT05285891",
"title": "Randomized, Blinded Discontinuation Trial of Ocrelizumab in Early Relapsing Multiple Sclerosis (AMS05)",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2031-08-25",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07509151",
"publication_url": "https://clinicaltrials.gov/study/NCT07509151",
"title": "A Phase III, Randomised, Open-label, Multicentre, Study of Surovatamig as Consolidation Therapy Versus Observation After First-line Induction Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV (SOUNDTRACK-C1)",
"has_exemption": false,
"start_date": "2026-05-05",
"completion_date": "2031-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/study/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538091",
"publication_url": "https://clinicaltrials.gov/study/NCT05538091",
"title": "Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ronald Buckanovich",
"sponsor_slug": "ronald-buckanovich",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06922318",
"publication_url": "https://clinicaltrials.gov/study/NCT06922318",
"title": "A Phase II Study of Sequential Bipolar Androgen Therapy and ZEN-3694 in Sequence With Enzalutamide + ZEN-3694 in Asymptomatic Patients With Metastatic CRPC: The COSMYC Trial (COmbined Suppression of MYC)",
"has_exemption": false,
"start_date": "2025-08-19",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228221",
"publication_url": "https://clinicaltrials.gov/study/NCT07228221",
"title": "iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathon Myers",
"sponsor_slug": "jonathon-myers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00969111",
"publication_url": "https://clinicaltrials.gov/study/NCT00969111",
"title": "Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy",
"has_exemption": false,
"start_date": "2009-08-31",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}